Find News

Filter articles

Showing 51 to 60 of 2294 results

Pfizer teams up with Nektar in oncology deal


Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company.

German patent court publishes reasoning in Gilead SPC dispute


Germany’s Federal Patent Court has published the reasoning behind its decision to revoke Gilead Sciences’ supplementary protection certificate for HIV/AIDS treatment Truvada,

PhRMA shames Brazil and Thailand over patent backlogs


Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report. 

HGF hires former Roivant Sciences VP


HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

Cochlear ordered to pay $268m in patent clash


A US district court has ordered Australia-based Cochlear to pay $268 million in damages to the Alfred E Mann Foundation for Scientific Research and Advanced Bionics. 

Illumina buys rival Pacific Biosciences for $1.2bn


Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion. 

Gilead signs immuno-oncology deal with Tango


California-based Gilead Sciences has signed a collaboration agreement with Tango Therapeutics to discover and develop a pipeline of immuno-oncology treatments for cancer patients.

Former Genentech employees charged with trade secrets theft


Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

ERS Genomics licenses CRISPR patents to Cambridge University spin-out

EU, UK01-11-2018

The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK.

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition


Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Showing 51 to 60 of 2294 results